Humoral immune response after COVID-19 vaccination.

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00025567
• Lead Sponsor: Performa NordZentrum für Gesunde ArbeitArbeitsmedizinischer Dienst

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-16
• Study Completion: 2022-06-30
• Results First Posted: 2022-09-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 103

Inclusion Criteria

Condition after Corona vaccination. At least 2 weeks after the end of the vaccination series and not more than 3 months after the last vaccination.

Exclusion Criteria

End of vaccination series not earlier than 14 days to not longer than 3 months ago.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Achievement of a necessary number of study participants. Once the laboratory results of these individuals are available, primary conclusions can be made about the humoral immune response after COVID-19 vaccination.<br>

Secondary Outcome Measures

Name	Time	Method
Secondarily, a control of the antibody titers is planned approx. 6 months after the first examination in order to be able to make statements about the course.